EBAMed

Geneva, Switzerland · Founded 2018 · Privately Held (backing)

Developer of the next-generation radiation therapy technology designed to treat cardiac arrhythmias from outside the heart. EBAMed is based in Geneva, Switzerland and was founded in 2018. Its last reported valuation was $106 million in Jun 2025. It has raised $51.1 million.

Last reported valuation
$105.6M
Oct 2026
Priced at
—
Total raised
$51.1M
Last round
—

Who backs EBAMed?

13 investors
InvestorType
MassChallenge—
European Innovation CouncilVenture capital
Venture KickOther
CDP Venture Capital (Rome)Venture capital
European UnionOther
Venture (Switzerland)Other
LIFTTVenture capital
Panakes PartnersVenture capital
EFI Lake Geneva Ventures—
Elysia Capital—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

EBAMed investors

13 investors are on record for EBAMed, including MassChallenge, European Innovation Council, Venture Kick and CDP Venture Capital (Rome).

Free account
More of EBAMed with a free account
  • ·The complete investor list: 13 names
  • ·Watch EBAMed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like EBAMed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View